PETACH TIKVA, Israel, October 28, 2014 /PRNewswire/ --
OrSense Ltd., developer of solutions for non-invasive measurements of hemoglobin, today announces a first delivery of its NBM200 non-invasive Hemoglobin testing systems in Mexico.
The delivery of systems comes after a successful evaluation of the NBM200 by Falcón, OrSense's distributor to Mexico and Banco Central de Sangre CMN La Raza, one of the largest blood collection centers in Mexico. Mexico is the second major market in Latin America embracing the NBM-200 in the last 6 months, following the commencement of distribution in Brazil.
Non invasive Hemoglobin testing uses optical measurement to replace traditional invasive blood testing. The NBM200 offers accurate, painless, Hb measurements on location. The non-invasive test further reduces infection risk as no blood is drawn, and with no consumables such as lancets, gloves etc. and no need for hazardous waste handling the system is also environmentally friendly.
Commented Yoav Reisman, CEO of Orsense: "The NBM200 is the most common Non invasive Hb screening product in blood banks today, in use by dozens of operators around the world. We introduced it in Brazil a few months ago and are pleased to have it now launched to the Mexican market. We are working closely with Falcón and are confident that users in Mexico will appreciate the benefits that others are already enjoying".
About OrSense
OrSense is a medical device company developing and marketing non-invasive monitoring systems for measurement of Hemoglobin. OrSense's systems are available and been successfully installed in dozens of blood donation facilities worldwide. OrSense's products are based on its proprietary Occlusion Spectroscopy technology. For additional information, please visit OrSense's website at http://www.orsense.com.
About Falcon
Instrumentos y equipos Falcón is a market leading distributor of medical equipment to the Mexican market. Founded in 1979 Falcon provides a broad range of services including marketing, distribution, sale and technical support of equipment and reagents for clinical diagnosis, blood banks, tomography, imaging, industrial and bioresearch. For additional information, please visit Falcón's website at http://www.falconmx.com.
About OrSense's Technology
OrSense's NBM200 is based on the company's proprietary SpectOLight™ technology, which uses an optical measurement platform combined with a ring-shaped sensor that is fitted on the subject's finger. A gentle pressure is applied by the sensor, temporarily occluding the blood flow in the finger. New blood dynamics are created, generating a unique, strong optical transmission signal, with a high signal-to-noise ratio which is wholly blood specific. During the occlusion, optical elements in the sensor perform a sensitive measurement of the light transmitted through the finger. This method, called Occlusion Spectroscopy, provides a quick, accurate and painless measurement of the subject's blood constituents.
Orsense Ltd. contact:
Mikael Flensburg
Chief Commercial Officer
OrSense Ltd.
Mobile: +46(0)760-477090
E-mail: [email protected]
SOURCE OrSense Ltd.
Share this article